A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 64, Issue 7, Pages e26409
Publisher
Wiley
Online
2016-12-30
DOI
10.1002/pbc.26409
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model
- (2015) Diane E. Cole et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PI3K/AKT signaling pathway and cancer: an updated review
- (2014) Miriam Martini et al. ANNALS OF MEDICINE
- Current View on the Mechanism of Action of Perifosine in Cancer
- (2014) Joachim Fensterle et al. Anti-Cancer Agents in Medicinal Chemistry
- A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms
- (2014) William D. Figg et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid
- (2014) Long N. Nguyen et al. NATURE
- A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study
- (2014) Maryam Fouladi et al. PEDIATRIC BLOOD & CANCER
- Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas
- (2013) B. S. Paugh et al. CANCER RESEARCH
- Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
- (2013) David T W Jones et al. NATURE GENETICS
- Anticancer mechanisms and clinical application of alkylphospholipids
- (2012) Wim J. van Blitterswijk et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Perifosine-induced inhibition of akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo
- (2011) Zhijie Li et al. CANCER
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways
- (2011) N. Shukla et al. CLINICAL CANCER RESEARCH
- Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma
- (2011) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors
- (2011) Sheri L. Spunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma
- (2011) Kenneth L. Pitter et al. PLoS One
- Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets
- (2010) Maryam Zarghooni et al. JOURNAL OF CLINICAL ONCOLOGY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Heterozygosity for Pten Promotes Tumorigenesis in a Mouse Model of Medulloblastoma
- (2010) Robert C. Castellino et al. PLoS One
- The Genetic Landscape of the Childhood Cancer Medulloblastoma
- (2010) D. W. Parsons et al. SCIENCE
- Protein Expression of Platelet-Derived Growth Factor Receptor Correlates with Malignant Histology and PTEN with Survival in Childhood Gliomas
- (2008) H. K. Thorarinsdottir et al. CLINICAL CANCER RESEARCH
- PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo
- (2008) D. Hambardzumyan et al. GENES & DEVELOPMENT
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started